shortagewatch

Home / Anti-infectives / Molnupiravir

ATC J05AB18 · Nucleosides and Nucleotides excl. Reverse Transcriptase Inhibitors · updated 2 Nov 2026

Molnupiravir shortage

As of 2 Nov 2026, Molnupiravir has a reported shortage in 1 of the 16 countries we track (United States), covering 3 products from 1 company.

Is there a Molnupiravir shortage?

Yes. As of 2 Nov 2026, Molnupiravir is reported short in 1 of the 16 countries we track: United States. No company has given a return date. New since 3 Oct 2026: United States.

Countries1/16
Products3packs or presentations
Companies11 listed
Short since20 Oct 202613 days ago
Earliest returnnot givencompany estimate
Main reasonNot stated
United States3 products shortCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

United States
Lagevrio, Capsule, 200 mg (NDC 0006-5055-06)Lagevrio, Capsule, 200 mg (NDC 0006-5055-06)Lagevrio, Capsule, 200 mg (NDC 0006-5055-07)Lagevrio, Capsule, 200 mg (NDC 0006-5055-07)Lagevrio, Capsule, 200 mg (NDC 0006-5055-09)Lagevrio, Capsule, 200 mg (NDC 0006-5055-09)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Merck & Co. (MSD)3 MRK

Listed: Merck & Co. (MSD) MRK · NYSE

Compared with similar medicines

ATC group J05AB · Nucleosides and Nucleotides excl. Reverse Transcriptase Inhibitors
Valaciclovir10/16Aciclovir6/16Valganciclovir5/16Famciclovir2/16Molnupiravir1/16Remdesivir1/16Ribavirin1/16

Affected products

CountryProductCompanySinceExpected backReason
USLagevrio, Capsule, 200 mg (NDC 0006-5055-06) discontinuationMerck Sharp & Dohme LLC20 Oct 2026not givenNot stated
USLagevrio, Capsule, 200 mg (NDC 0006-5055-07) discontinuationMerck Sharp & Dohme LLC20 Oct 2026not givenNot stated
USLagevrio, Capsule, 200 mg (NDC 0006-5055-09) discontinuationMerck Sharp & Dohme LLC20 Oct 2026not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Molnupiravir shortage?

Yes. As of 2 Nov 2026, Molnupiravir is reported short in 1 of the 16 countries we track: United States. No company has given a return date. New since 3 Oct 2026: United States.

When will Molnupiravir be back in stock?

No return date has been given; United States: no date given. These are company estimates reported to each authority.

Why is Molnupiravir in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Molnupiravir shortages?

Merck & Co. (MSD).